title: Does angiotensin I-converting enzyme inhibitor therapy have an antiproliferative effect on blood-forming bone marrow?
authors.forename: A
authors.initials: A
authors.lastname: Vasků
authors.forename: M
authors.initials: M
authors.lastname: Soucek
authors.forename: V
authors.initials: V
authors.lastname: Znojil
authors.forename: I
authors.initials: I
authors.lastname: Rihácek
authors.forename: K
authors.initials: K
authors.lastname: Cídl
authors.forename: L
authors.initials: L
authors.lastname: Strelcová
authors.forename: J
authors.initials: J
authors.lastname: Vácha
mesh_terms: D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D001854:Bone Marrow Cells / Q000187:drug effects*; D004920:Erythropoiesis / Q000187:drug effects*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors